ENROLLMENT
69%
124 / 180 patients
BUDGET
60%
$2.2M /$ $3.6M
SCREEN FAILURES
12.7%
vs 15.0% benchmark
ACTIVE SITES
2
4.0 total FTE
MILESTONES
2/5
40% complete
ENROLLMENT TRENDS
No projection data available
BUDGET BREAKDOWN
TOTAL BUDGET
$3.60M
CONSUMED
$2.16M
60%
REMAINING
$1.44M
+3% INF$1.48M
Passthrough
$1.44M (40%)
40%
Investigator Fees
$0.90M (25%)
25%
Consumed
$2.16M (60%)
60%
Remaining
$1.44M (40%)
40%
AVG COST PER PATIENT
$20,000
CURRENT BURN RATE
$17,419.355/pt
SITE PERFORMANCE
| SITE | STATUS | ENROLLMENT | TARGET | PROGRESS | SCREEN FAIL | FTE |
|---|---|---|---|---|---|---|
Memphis | 64 | 90 | 71% | 12.3% | 2 | |
Chattanooga | 60 | 90 | 67% | 13.0% | 2 |
RISK REGISTER
MILESTONES
First Patient Enrolled
Target: 7/15/2024 • Completed: 7/12/2024
50% Enrollment
Target: 4/1/2025 • Completed: 3/28/2025
75% Enrollment
Target: 9/1/2025
Last Patient Enrolled
Target: 12/31/2025
Database Lock
Target: 4/30/2026
TRIAL INFORMATION
Protocol Version:1.0
Sponsor:Endocrine Solutions Inc
Therapeutic Area:Endocrinology
Start Date:7/1/2024
Est. Completion:4/30/2026
Passthrough:$1.44M
Per Patient:$8,000
Investigator Fees:$5,000/pt